SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-21-000020
Filing Date
2021-03-19
Accepted
2021-03-19 16:47:24
Documents
8
Period of Report
2021-03-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIORESTORATIVE FORM 8-K DATED MARCH 18, 2021 form8kdtd031821.htm 8-K 21585
2 2021 STOCK INCENTIVE PLAN ex99_1.htm EX-99.1 125407
3 LANCE ALSTODT EMPLOYMENT AGREEMENT ex99_2.htm EX-99.2 99977
4 FRANCISCO SILVA EMPLOYMENT AGREEMENT ex99_3.htm EX-99.3 98267
5 LANCE ALSTODT NON-QUALIFIED STOCK OPTION AWARD AGREEMENT ex99_4.htm EX-99.4 43985
6 FRANCISCO SILVA NON-QUALIFIED STOCK OPTION AWARD AGREEMENT ex99_5.htm EX-99.5 44054
7 LANCE ALSTODT RESTRICTED STOCK UNIT AWARD AGREEMENT ex99_6.htm EX-99.6 44586
8 FRANCISCO SILVA RESTRICTED STOCK UNIT AWARD AGREEMENT ex99_7.htm EX-99.7 44609
  Complete submission text file 0001021771-21-000020.txt   523777
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 21758806
SIC: 8090 Services-Misc Health & Allied Services, NEC